# Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke

> **NCT01762163** · PHASE4 · COMPLETED · sponsor: **China Academy of Chinese Medical Sciences** · enrollment: 622 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Qizhitongluo Capsule
- **DRUG:** Naoxintong Capsule
- **DRUG:** Aspirin Enteric-coated Tablets
- **BEHAVIORAL:** the routine recovery training
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01762163
- **Lead sponsor:** China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 622 (ACTUAL)
- **Last updated:** 2016-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01762163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01762163, "Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01762163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*